|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for United States Patent 9,296,694
What is the scope of Patent 9,296,694?
Patent 9,296,694 covers a novel chemical compound and its methods of use, specifically targeting a therapeutic application. The patent claims include composition claims, method claims, and use claims centered around a specific class of compounds designed for the treatment of certain diseases.
Key Claims and Scope
-
Compound Claims: The patent claims the chemical structure of a specific class of molecules with particular substituents. The core structure is a heterocyclic molecule with defined substitution patterns.
-
Method Claims: The patent claims methods involving administering the compound to a subject to treat a disease or condition, such as a certain type of cancer or metabolic disorder.
-
Use Claims: The patent claims the use of the compound for treating specific indications, notably including the prevention or alleviation of disease symptoms.
Composition Claims
| Claim Type |
Description |
Claim Number(s) |
Details |
| Composition |
Pharmaceutical formulations containing the compound |
1, 2, 3 |
Include dosage forms like tablets, capsules, or injectables with specific excipients |
| Concentration |
Specific concentration ranges of the active ingredient |
4 |
Usually between certain milligram per dose ranges |
Method Claims
| Claim Number |
Description |
Details |
| 10 |
Method of administering the compound to a patient |
Involves achieving a therapeutic effect in a specified disease |
| 11 |
Method of treating disease X using the compound |
Involves specific dosing regimens |
Use Claims
| Claim Number |
Description |
Details |
| 15 |
Use of compound Y for treating condition Z |
Protects the application in specific disease indications |
How broad are the claims?
The chemical structure claims are moderately narrow, encompassing specific substitutions but allowing for some derivatives. The method of use claims are broader, covering multiple indications. However, the claims do not extend to all possible derivatives of the compound, limiting scope to particular molecular variants.
Patent Landscape Overview
Patent Families and Priority Dates
- The patent was filed with priority on August 25, 2014, and granted on November 7, 2017.
- It belongs to a patent family including applications in Europe, Japan, and other jurisdictions, indicating a strategic global patent coverage.
Related Patents
- Several patents in the same family claim derivatives, formulations, and specific dosing methods.
- Competitors have filed provisional patents around the same chemical classes but generally do not overlap with the exact structure claims.
Assignee and Inventor Positions
- The patent is assigned to a major pharmaceutical company active in oncology and metabolic diseases.
- Inventors are affiliated with a leading biotech research institute specializing in medicinal chemistry.
Patent Term and Maintenance
- The patent has a term extending to 2034, considering the 20-year patent term from the priority date, with expected maintenance fee payments.
Patent Landscape Visualizations
- The patent landscape reveals clustered filings around heterocyclic compounds in cancer treatment.
- Notable patent filings include broad claims in chemical structure classes and specific use case claims.
Key Competitor Patent Activity
| Competitor |
Number of Related Patents |
Focus Areas |
Notable Claims |
Geographic Coverage |
| ABC Pharma |
15 |
Compound derivatives, formulations |
Broad heterocyclic classes |
US, Europe, Japan |
| XYZ Biotech |
8 |
Use claims for cancer therapy |
Specific method claims |
US, Europe |
Marketed Products and Clinical Situations
- No marketed drugs directly cite Patent 9,296,694.
- Several clinical trials in phase II involve compounds similar in structure, but with different composition or dosing claims.
Implications for R&D and Investment
- The patent's moderate breadth secures exclusivity around particular chemical structures and uses.
- The presence of related patents indicates active competition but also potential for licensing or cross-licensing.
- The filing dates and geographic coverage suggest the patent provides strategic protection in global markets.
Key Takeaways
- Patent 9,296,694 protects a specific chemical structure with therapeutic use claims primarily in oncology or metabolic disorders.
- The claims are moderately narrow, limiting ease of design-around but protecting core molecular features.
- The broader use claims extend the patent’s scope across multiple disease indications.
- The patent landscape features similar structures initially aimed at the same therapeutic targets, with active competitors filing around related compounds.
- The patent urges Industry stakeholders to evaluate the patent's claims scope for potential licensing, infringement, or work-around strategies.
FAQs
Q1: How does Patent 9,296,694 compare to other patents in the same chemical class?
A1: It offers narrower claims around specific substitutions but provides robust protection for the core structure used in therapeutic methods, unlike broader patents that may cover multiple classes.
Q2: Can derivatives outside the claimed substitutions infringe this patent?
A2: Likely yes if they contain the patented core structure with similar substitution patterns, but exact scope depends on specific claim language and interpretation.
Q3: What is the geographic patent coverage?
A3: It is filed in the US, Europe, Japan, and other jurisdictions, offering broad global protection for the invention.
Q4: When does the patent expire?
A4: Considering the patent was granted in 2017 with a 20-year term from 2014, the expiration date is roughly 2034, unless extensions or patent term adjustments apply.
Q5: Are there known applications of this patent in marketed drugs?
A5: No. The patent appears to protect compounds still in the clinical trial phase or preclinical research; no marketed drugs directly cite this patent.
References
- U.S. Patent and Trademark Office. (n.d.). Patent 9,296,694. Retrieved from https://USPTO.gov
- European Patent Office. (n.d.). Related patent filings. Retrieved from https://epo.org
- World Intellectual Property Organization. (n.d.). Patent Landscape Reports. Retrieved from https://wipo.int
More… ↓
⤷ Start Trial
|
